Nationwide Fund Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-7,044
| Closed | -$1.16M | – | 1109 |
|
|
2017
Q3 | $1.16M | Buy |
7,044
+5,624
| +396% | +$926K | ﹤0.01% | 1702 |
|
|
2017
Q2 | $193K | Sell |
1,420
-2,348
| -62% | -$319K | ﹤0.01% | 2636 |
|
|
2017
Q1 | $726K | Buy |
3,768
+2,402
| +176% | +$463K | ﹤0.01% | 1942 |
|
|
2016
Q4 | $193K | Buy |
1,366
+341
| +33% | +$48.2K | ﹤0.01% | 2618 |
|
|
2016
Q3 | $150K | Sell |
1,025
-392
| -28% | -$57.4K | ﹤0.01% | 2765 |
|
|
2016
Q2 | $143K | Buy |
1,417
+392
| +38% | +$39.6K | ﹤0.01% | 2765 |
|
|
2016
Q1 | $137K | Hold |
1,025
| – | – | ﹤0.01% | 2702 |
|
|
2015
Q4 | $204K | Buy |
1,025
+31
| +3% | +$6.17K | ﹤0.01% | 2548 |
|
|
2015
Q3 | $157K | Hold |
994
| – | – | ﹤0.01% | 2691 |
|
|
2015
Q2 | $406K | Buy |
994
+270
| +37% | +$110K | ﹤0.01% | 2362 |
|
|
2015
Q1 | $332K | Buy |
724
+34
| +5% | +$15.6K | ﹤0.01% | 2451 |
|
|
2014
Q4 | $388K | Hold |
690
| – | – | ﹤0.01% | 2331 |
|
|
2014
Q3 | $361K | Buy |
690
+57
| +9% | +$29.8K | ﹤0.01% | 2402 |
|
|
2014
Q2 | $442K | Sell |
633
-40
| -6% | -$27.9K | ﹤0.01% | 2328 |
|
|
2014
Q1 | $312K | Sell |
673
-176
| -21% | -$81.6K | ﹤0.01% | 2289 |
|
|
2013
Q4 | $292K | Buy |
+849
| New | +$292K | ﹤0.01% | 2496 |
|